Artificial intelligence is rapidly becoming embedded across the healthcare ecosystem—not just in standalone applications, but within the vendors and products healthcare organizations already depend on. From clinical decision support and imaging analysis to revenue cycle management and administrative workflows, AI is reshaping how healthcare operates.
As AI becomes embedded across the ecosystem, third-party risk becomes fundamentally different..
Healthcare organizations have spent years building mature third-party risk management (TPRM) programs to evaluate vendors, protect sensitive data, and strengthen cybersecurity. Those foundations remain essential. But AI introduces a new visibility challenge.
You can't govern what you can't see.
Visibility remains one of the biggest barriers to effective AI governance. In fact, Censinet's 2026 Healthcare Cybersecurity & AI Benchmarking Study found that only 30% of healthcare organizations maintain an inventory of AI across their environments.
Without visibility into where AI exists, which critical healthcare functions depend on it, and how AI changes risk, organizations cannot govern it effectively.
The following four questions can help healthcare organizations gain clarity on where AI exists across their third-party ecosystem, uncover hidden dependencies, and build the visibility needed to govern AI effectively.
AI Doesn't Just Introduce New Risk
It introduces exposure you may not even know exists.
AI is increasingly embedded within the vendors and products healthcare organizations already rely on—often without creating any obvious signal that their risk profile has changed.
The greatest challenge isn't simply managing AI risk—it's understanding where AI exposure already exists.
Unlike traditional software, AI continuously evolves. Vendors introduce new capabilities and increasingly embed AI into products healthcare organizations already use across clinical and operational workflows. As a result, healthcare organizations must evaluate not only the vendor itself, but also how AI supports critical healthcare functions and the operational dependencies it creates .
Effective AI governance starts with visibility. Organizations must first understand where AI exists before they can assess its risk, apply appropriate governance, and continuously monitor it over time.
1. Do You Know Which Products in Your Ecosystem Are Actually Using AI?
Nearly every technology vendor now claims to be "AI-powered." But that label can describe everything from simple automation to generative AI or autonomous AI agents.
The first step toward effective AI governance is understanding where AIexists across your third-party ecosystem——and the operational dependencies it creates.
Once you've identified where AI exists, the next step is understanding how responsibly it's being developed and governed. Start by asking:
- What type of AI or machine learning model is being used?
- How was the model trained, and what safeguards exist to reduce bias?
- Can the vendor explain how the model produces its outputs?
- How does the vendor demonstrate alignment with established AI governance frameworks such as the NIST AI Risk Management Framework?
These questions aren't just about understanding the AI. They're about understanding whether you can trust how it's governed.
2. Which Critical Healthcare Functions Depend on That AI?
Not every AI-enabled vendor or product presents the same level of risk.
The more important question isn't whether AI exists. It's what depends on it.
An AI application supporting diagnostic imaging creates very different operational exposure than one used for marketing automation. Likewise, AI embedded within revenue cycle management, pharmacy, clinical documentation, or supply chain operations creates different operational dependencies that shape how risk should be prioritized.
Organizations should evaluate AI in the context of its operational impact, including:
- The sensitivity of the data it processes, including protected health information (PHI)
- Whether it supports clinical or administrative workflows
- Whether it informs human decision-making or performs autonomous actions
- Which critical healthcare functions depend on the technology
Understanding those dependencies helps organizations prioritize risk, engage the right stakeholders, and focus governance where disruption would have the greatest operational impact.
Risk rarely exists within a single AI-enabled vendor or product. It extends across the critical healthcare functions that depend on it—and ultimately to the organization's ability to deliver care.
3. Can Your AI Risk Review Keep Pace with Procurement?
AI introduces new considerations into vendor risk assessments, but governance shouldn't become a bottleneck to innovation.
Evaluating AI often requires collaboration across cybersecurity, compliance, privacy, legal, procurement, operations, data governance, and clinical leadership. Without a structured process, coordinating those stakeholders can delay procurement,create unnecessary friction and slow AI adoption.
The objective isn't to reduce diligence. It's to reduce administrative work.
Modern healthcare organizations are increasingly automating AI risk assessment workflows by routing reviews to the appropriate stakeholders, leveraging vendor documentation to reduce manual effort, and surfacing findings that require expert judgement.
By automating routine tasks, organizations enable subject matter experts to focus where they create the most value—applying their expertise to the risks that matter most.
4. How Often Should You Reassess AI-Enabled Vendors and Products?
Unlike traditional software, AI evolves continuously.
Vendors introduce new models and capabilities, existing products become AI-enabled, and new use cases emerge long after procurement is complete. As AI evolves, so does an organization's risk exposure.
A one-time assessment captures risk at a moment in time. AI doesn't stand still—and neither should governance.
That makes reassessment an essential part of AI governance—not just at procurement, but throughout the lifecycle of the technology.
AI moves faster than procurement cycles. Governance needs to keep pace.
Reassessment should be driven by the potential business impact of the technology and the risk it introduces.
While every organization's governance model will differ, a practical approach is to align reassessment frequency with the operational impact of the technology. For example:
- High: AI supporting patient care, clinical decision-making, or regulatory compliance should be reassessed at least annually—and, where possible, monitored continuously for meaningful changes in capability, use, or risk.
- Moderate: AI supporting business operations that supports important business operations but is not directly tied to patient care should be reassessed every one to two years, with ongoing monitoring for meaningful changes.
- Low: AI with limited operational impact may only require reassessment at contract renewal or when significant changes are introduced to the technology.
Reassessments shouldn't be driven solely by scheduled review cycles. Significant changes to an AI model, its functionality, or its intended use should trigger a reassessment regardless of where the technology is in its contract lifecycle.
AI moves faster than procurement cycles. Governance needs to keep pace.
From Assessment to Intelligence
The goal of third-party AI risk management isn't simply to complete another assessment.
It's to understand where AI exists across your third-party ecosystem, which critical healthcare functions depend on it, and how those risks affect your broader enterprise risk management (ERM) program.
When organizations connect AI-enabled vendors and products to the critical healthcare functions they support, assessments become more than compliance exercises. They become a source of actionable intelligence—helping leaders understand what matters most, prioritize risk, engage the right stakeholders, and make faster, more informed decisions.
That's where Healthcare Risk Intelligence™ turns visibility into actionable intelligence.
The Censinet RiskOps™ platform helps healthcare organizations operationalize that approach by identifying AI-enabled vendors and products, automating AI-specific risk assessments, mapping third-party technologies to critical healthcare functions, and continuously monitoring changes across the vendor ecosystem.
Ready to See Healthcare Risk Intelligence™ in Action?
See how Healthcare Risk Intelligence™ helps healthcare organizations uncover hidden AI exposure, understand operational dependencies, and make more informed decisions.
Discover how the Censinet RiskOps™ platform identifies AI-enabled vendors and products, maps them to critical healthcare functions, automates AI-specific risk assessments, and continuously monitors changes across your third-party ecosystem.
Request a personalized demonstration.
